Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection

Completed · Phase 3

Conditions studied: Febrile Neutropenia

In brief

This study will treat patients who have fever and neutropenia (after cancer chemotherapy) that is possibly due to a specific bacteria (gram positive bacteria).

Key facts

Study ID

NCT00035425

Run by

Pfizer

People needed

120

Starts

2001-11-01

Expected to finish

2002-11-01

Last updated by the study team

2009-12-01

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have neutropenia (ANC less than 500) with fever (oral temp 38.3 C).
• Patients must have a cancer with recent chemotherapy and risks factors for gram positive infections.

You may not qualify if…

• Patients with fever due to known causes. Patients with HIV. Patients with recent bone marrow transplant. Patients with an infected indwelling catheter that cannot be removed. Patients who have received more than one day of another antibiotic before entering the trial.
• Patients with endocarditis, osteomyelitis, meningitis, CNS infections.

Where it is running

• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — Springfield, Illinois, United States
• Pfizer Investigational Site — Springfield, Illinois, United States
• Pfizer Investigational Site — Springfield, Illinois, United States
• Pfizer Investigational Site — Springfield, Illinois, United States
• Pfizer Investigational Site — The Bronx, New York, United States
• Pfizer Investigational Site — The Bronx, New York, United States
• Pfizer Investigational Site — Houston, Texas, United States
• Pfizer Investigational Site — Richmond, Virginia, United States
• Pfizer Investigational Site — Richmond, Virginia, United States
• Pfizer Investigational Site — Richmond, Virginia, United States
• Pfizer Investigational Site — Richmond, Virginia, United States
• Pfizer Investigational Site — Richmond, Virginia, United States
• Pfizer Investigational Site — Federal Way, Washington, United States
• Pfizer Investigational Site — Lakewood, Washington, United States
• Pfizer Investigational Site — Tacoma, Washington, United States
• Pfizer Investigational Site — Buenos Aires, Argentina
• Pfizer Investigational Site — Córdoba, Argentina
• Pfizer Investigational Site — Mendoza, Argentina
• Pfizer Investigational Site — Porto Alegre, Rio Grande do Sul, Brazil
• Pfizer Investigational Site — Porto Alegre, Rio Grande do Sul, Brazil
• Pfizer Investigational Site — São Paulo, São Paulo, Brazil
• Pfizer Investigational Site — São Paulo, São Paulo, Brazil
• Pfizer Investigational Site — São Paulo, São Paulo, Brazil
• Pfizer Investigational Site — São Paulo, São Paulo, Brazil

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.